Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18660859 | DRUG DELIVERY DEVICE AND METHODS FOR USING SAME | May 2024 | January 2025 | Allow | 9 | 1 | 0 | No | No |
| 18642324 | OCULAR IMPLANTS FOR DELIVERY INTO AN ANTERIOR CHAMBER OF THE EYE | April 2024 | February 2025 | Allow | 10 | 1 | 0 | No | No |
| 18639054 | APERTURED NONWOVEN WEBS | April 2024 | November 2024 | Allow | 7 | 1 | 0 | No | No |
| 18616791 | ABSORBENT ARTICLE WITH FUNCTION-FORMED TOPSHEET, AND METHOD FOR MANUFACTURING | March 2024 | June 2025 | Allow | 14 | 1 | 0 | No | No |
| 18606596 | MEDICAL DEVICES FOR DELIVERING PLUGS TO VOIDS | March 2024 | September 2024 | Allow | 6 | 0 | 0 | Yes | No |
| 18604007 | WOUND THERAPY SYSTEM WITH INSTILLATION THERAPY AND DYNAMIC PRESSURE CONTROL | March 2024 | April 2025 | Allow | 14 | 1 | 1 | Yes | No |
| 18586901 | HEMORRHAGE MANAGEMENT SYSTEM | February 2024 | September 2024 | Allow | 7 | 0 | 0 | No | No |
| 18425308 | DISPOSABLE ABSORBENT ARTICLE | January 2024 | November 2024 | Allow | 10 | 1 | 0 | No | No |
| 18422954 | COMBINATION FLUID INSTILLATION AND NEGATIVE PRESSURE DRESSING | January 2024 | March 2025 | Abandon | 14 | 0 | 1 | No | No |
| 18397981 | WOUND CLOSURE DEVICE AND METHOD OF USE | December 2023 | July 2024 | Allow | 7 | 0 | 0 | Yes | No |
| 18393451 | CONNECTED BODY SURFACE CARE MODULE | December 2023 | July 2025 | Allow | 19 | 2 | 0 | No | No |
| 18382247 | DRAINAGE SYSTEM WITH O-RING | October 2023 | May 2024 | Allow | 7 | 0 | 0 | No | No |
| 18368225 | SYSTEMS AND METHODS FOR REDUCING PRESSURE AT AN OUTFLOW OF A DUCT | September 2023 | August 2024 | Allow | 11 | 1 | 0 | Yes | No |
| 18224454 | SYSTEMS AND METHODS FOR DETERMINING BLOCKAGES IN A NEGATIVE PRESSURE WOUND THERAPY SYSTEM | July 2023 | April 2024 | Allow | 9 | 0 | 0 | Yes | No |
| 18337465 | Undergarment Device with a Replaceable Section | June 2023 | January 2026 | Abandon | 31 | 1 | 0 | No | No |
| 18207601 | WOUND TREATMENT APPARATUSES AND METHODS WITH NEGATIVE PRESSURE SOURCE INTEGRATED INTO WOUND DRESSING | June 2023 | May 2025 | Allow | 23 | 1 | 1 | No | No |
| 18330682 | ABSORBENT ARTICLE WITH IMPROVED LAMINATE TOPSHEET | June 2023 | February 2026 | Allow | 32 | 2 | 0 | No | No |
| 18254982 | WOUND DRESSING | May 2023 | July 2024 | Allow | 13 | 3 | 0 | Yes | No |
| 18201385 | POWDER DISPENSING APPLICATOR | May 2023 | December 2025 | Abandon | 31 | 4 | 0 | No | No |
| 18321631 | Dispenser Actuator Assembly | May 2023 | March 2025 | Allow | 22 | 1 | 0 | No | No |
| 18187629 | MATERIALS AND METHODS OF MANUFACTURING RELATED TO APPARATUS FOR COLLECTING URINE | March 2023 | March 2026 | Abandon | 36 | 1 | 1 | No | No |
| 18123486 | CUSTOMIZABLE WOUND CLOSURE DEVICE AND METHOD OF USE | March 2023 | June 2024 | Allow | 15 | 1 | 0 | No | No |
| 18122882 | PREOPERATIVE SKIN PREPARATION APPLICATOR | March 2023 | October 2025 | Allow | 31 | 1 | 0 | No | No |
| 18183849 | CONNECTED BODY SURFACE CARE MODULE | March 2023 | October 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18119326 | IMAGING PLACED CATHETER | March 2023 | January 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18173932 | ABSORBENT ARTICLE FOR PET | February 2023 | March 2026 | Allow | 37 | 2 | 0 | No | No |
| 18111770 | HYBRID DRAPE HAVING A GEL-COATED PERFORATED MESH | February 2023 | March 2025 | Abandon | 25 | 2 | 0 | No | No |
| 18111158 | PH SENSING FOR SENSOR ENABLED NEGATIVE PRESSURE WOUND MONITORING AND THERAPY APPARATUSES | February 2023 | June 2024 | Allow | 16 | 1 | 0 | Yes | No |
| 18096937 | NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES AND METHODS WITH INTEGRATED ELECTRONICS | January 2023 | June 2024 | Allow | 17 | 1 | 0 | No | No |
| 18075582 | ABSORBENT ARTICLE WITH A DISTRIBUTION LAYER COMPRISING CHANNELS | December 2022 | December 2024 | Allow | 24 | 2 | 0 | No | No |
| 18059750 | Transfer Pad with Moisture Control | November 2022 | February 2026 | Allow | 39 | 2 | 0 | No | No |
| 17993363 | CENTRIFUGAL IMPELLER FOR BLOOD PUMP, AND BLOOD PUMP | November 2022 | September 2025 | Allow | 34 | 1 | 0 | No | No |
| 17991528 | SYSTEM AND METHOD FOR IMPROVING BATTERY LIFE OF PORTABLE NEGATIVE-PRESSURE THERAPY THROUGH HYSTERESIS CONTROL | November 2022 | December 2023 | Allow | 13 | 0 | 0 | No | No |
| 17925412 | SEMEN COLLECTION SHEET | November 2022 | October 2025 | Allow | 35 | 2 | 0 | No | No |
| 17924200 | ABSORBENT ARTICLE WITH IMPROVED STRUCTURAL FUNCTIONALITY COMMUNICATION | November 2022 | November 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17978867 | TOPICAL APPLICATOR | November 2022 | October 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17773777 | DISPOSABLE WEARING ARTICLE | October 2022 | June 2025 | Allow | 37 | 1 | 0 | Yes | No |
| 17919624 | PANT-TYPE ABSORBENT ARTICLE | October 2022 | June 2025 | Allow | 32 | 1 | 0 | No | No |
| 17954950 | DEVICE AND METHOD FOR WOUND THERAPY | September 2022 | May 2025 | Abandon | 31 | 1 | 0 | No | No |
| 17913502 | DEVICE AND METHOD FOR DETERMINATION OF A CO2 PARTIAL PRESSURE VALUE ON A BLOOD SIDE OF AN OXYGENATOR | September 2022 | October 2025 | Allow | 36 | 0 | 1 | No | No |
| 17950495 | BLOOD RESERVOIR WITH BLOOD-HANDLING ASSEMBLY | September 2022 | March 2024 | Allow | 18 | 1 | 0 | No | No |
| 17909089 | OCULAR IMPLANT AND METHOD OF MAKING SAME | September 2022 | September 2025 | Allow | 36 | 2 | 1 | Yes | No |
| 17880132 | SKIN TREATMENT AND BEAUTY MANAGEMENT DEVICE | August 2022 | July 2024 | Abandon | 24 | 1 | 0 | No | No |
| 17871682 | KIT FOR USE WITH A SELECTIVELY CONFIGURABLE WOUND DRESSING | July 2022 | September 2025 | Allow | 38 | 2 | 0 | Yes | No |
| 17871690 | SELECTIVELY CONFIGURABLE WOUND DRESSING | July 2022 | August 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17853139 | SYSTEMS AND METHODS FOR APPLYING REDUCED PRESSURE THERAPY | June 2022 | May 2025 | Allow | 34 | 1 | 1 | Yes | No |
| 17853029 | WOUND DRESSING AND METHOD OF TREATMENT | June 2022 | June 2023 | Allow | 11 | 1 | 1 | Yes | No |
| 17625622 | Control for Non-Occlusive Blood Pumps | June 2022 | October 2025 | Allow | 45 | 2 | 0 | Yes | No |
| 17780534 | DEVICE AND METHOD FOR AIR-FREE FILLING OF A FLUID MANAGEMENT SYSTEM | May 2022 | June 2025 | Allow | 36 | 1 | 1 | No | No |
| 17775103 | CANNULA FOR APICAL CANNULATION | May 2022 | July 2025 | Allow | 38 | 2 | 0 | Yes | No |
| 17726892 | COLLAPSIBLE DRESSING FOR NEGATIVE PRESSURE WOUND TREATMENT | April 2022 | March 2026 | Allow | 46 | 1 | 0 | No | No |
| 17717825 | DRY COSMETIC SHEET | April 2022 | May 2025 | Abandon | 37 | 2 | 0 | No | No |
| 17766992 | APPARATUSES AND METHODS FOR NEGATIVE PRESSURE WOUND THERAPY | April 2022 | June 2025 | Allow | 38 | 3 | 0 | No | No |
| 17691021 | ATTACHABLE TIP FOR ELECTROMAGNETIC HAND PIECE | March 2022 | February 2024 | Allow | 23 | 3 | 0 | No | Yes |
| 17681948 | NEGATIVE PRESSURE WOUND THERAPY DRESSING AND RELATED APPARATUS | February 2022 | October 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17682261 | DRUG DELIVERY DEVICE AND METHODS FOR USING SAME | February 2022 | February 2024 | Allow | 23 | 4 | 0 | Yes | No |
| 17635866 | FLUID COLLECTION ASSEMBLY INCLUDING A REUSABLE FLUID IMPERMEABLE BARRIER AND AT LEAST ONE SINGLE USE WICKING CARTRIDGE | February 2022 | February 2026 | Allow | 48 | 1 | 0 | No | No |
| 17671996 | REDUCED PRESSURE THERAPY APPARATUSES AND METHODS OF USING SAME | February 2022 | January 2026 | Allow | 47 | 1 | 0 | Yes | No |
| 17587395 | AUTONOMOUS FLUID INSTILLATION SYSTEM AND METHOD WITH TISSUE SITE PRESSURE MONITORING | January 2022 | February 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17578535 | FILTRATION DEVICE AND SYSTEM | January 2022 | March 2025 | Allow | 38 | 1 | 1 | Yes | No |
| 17624880 | APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD AND METHOD FOR DETERMINING WATER LOSSES IN A MEMBRANE GAS EXCHANGER OF AN APPARATUS FOR EXTRACORPOREAL TREATMENT OF BLOOD | January 2022 | August 2025 | Allow | 43 | 1 | 0 | No | No |
| 17563524 | DEVICES AND METHODS FOR TREATING AND CLOSING WOUNDS WITH NEGATIVE PRESSURE | December 2021 | September 2024 | Abandon | 33 | 0 | 1 | No | No |
| 17597167 | WOUND-COVERING MATERIAL AND PRODUCTION METHOD THEREFOR | December 2021 | March 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17596702 | MEDICAL CONTAINER FOR FILLING WITH PROTEIN DRUGS | December 2021 | November 2024 | Abandon | 35 | 1 | 0 | No | No |
| 17527224 | PUMP DEVICE FOR PUMPING BLOOD | November 2021 | November 2025 | Allow | 48 | 2 | 0 | Yes | No |
| 17523321 | DEVICES AND METHODS FOR DELIVERY OF PHARMACEUTICAL COMPOSITIONS | November 2021 | August 2024 | Allow | 33 | 5 | 0 | Yes | No |
| 17514527 | DRAINAGE SYSTEM WITH RETENTION RING | October 2021 | December 2024 | Allow | 38 | 1 | 0 | No | No |
| 17513741 | APPARATUS AND METHOD FOR LOCATING FLUID LEAKS IN A REDUCED PRESSURE DRESSING UTILIZING A REMOTE DEVICE | October 2021 | March 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17505305 | NEGATIVE PRESSURE WOUND CLOSURE DEVICE | October 2021 | September 2024 | Abandon | 35 | 0 | 1 | No | No |
| 17603631 | WOUND OXYGEN TREATMENT SYSTEM | October 2021 | April 2025 | Allow | 42 | 1 | 0 | No | No |
| 17495134 | BODY CAVITY CONDUIT DEVICES, SYSTEMS, AND METHODS OF USE | October 2021 | January 2026 | Abandon | 51 | 3 | 0 | No | No |
| 17495603 | INTERACTIVE TABLET AND INTEGRATED FACIAL TREATMENT DEVICE | October 2021 | April 2022 | Allow | 7 | 1 | 0 | Yes | No |
| 17439582 | MEDICINAL PRODUCT COMPRISING A CONTAINER AND AN AQUEOUS LIQUID CONTAINING BICARBONATE | September 2021 | September 2024 | Allow | 36 | 1 | 0 | No | No |
| 17437032 | SYSTEM FOR THE PERCUTANEOUS APPLICATION OF A FLUID TO SKIN AREAS | September 2021 | November 2025 | Abandon | 50 | 1 | 1 | No | No |
| 17465816 | ON DEMAND DIALYSATE MIXING USING CONCENTRATES | September 2021 | July 2023 | Allow | 22 | 0 | 0 | Yes | No |
| 17463079 | DRUG DELIVERY DEVICE AND METHODS FOR USING SAME | August 2021 | November 2021 | Allow | 3 | 0 | 0 | Yes | No |
| 17398426 | NEGATIVE POISSON`S RATIO MATERIALS FOR MEDICAL APPLICATIONS | August 2021 | January 2025 | Allow | 41 | 1 | 1 | No | No |
| 17429508 | ABSORBENT ARTICLE | August 2021 | October 2025 | Allow | 50 | 3 | 0 | Yes | No |
| 17429549 | ABSORBENT ARTICLE WITH EMBOSSED SURFACE LAYER | August 2021 | October 2025 | Abandon | 50 | 3 | 0 | Yes | No |
| 17395857 | DISPOSABLE PROTECTION SHEET | August 2021 | December 2024 | Abandon | 41 | 4 | 0 | Yes | No |
| 17381717 | ABSORBENT ARTICLE WITH WAIST CONTAINMENT MEMBER AND METHOD OF MANUFACTURING THEREOF | July 2021 | April 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17344668 | ARRANGEMENTS AND METHODS FOR AVOIDING SPREADING OF INFECTIOUS AGENTS AND IMPROVING ELECTRIC SAFETY AND SUCTION PERFORMANCE OF A MEDICAL ASPIRATOR | June 2021 | February 2025 | Allow | 44 | 4 | 0 | No | No |
| 17339879 | CONTACTLESS WOUND TREATMENT BARRIER AND METHOD OF CONTACTLESS WOUND TREATMENT | June 2021 | September 2025 | Allow | 52 | 2 | 1 | Yes | No |
| 17337069 | PRESERVATIVE REMOVAL FROM EYE DROPS | June 2021 | February 2025 | Allow | 45 | 1 | 0 | Yes | No |
| 17335316 | HEMORRHAGE MANAGEMENT SYSTEM | June 2021 | October 2023 | Allow | 28 | 1 | 0 | Yes | No |
| 17294580 | WOUND DRESSING WITH FLUID MANAGEMENT | May 2021 | February 2026 | Allow | 57 | 4 | 1 | No | No |
| 17314699 | OCULAR IMPLANTS FOR DELIVERY INTO AN ANTERIOR CHAMBER OF THE EYE | May 2021 | January 2024 | Allow | 33 | 1 | 0 | No | No |
| 17239869 | OXYGENATOR UNIT WITH A PRESSURE RELIEF VALVE | April 2021 | April 2024 | Allow | 36 | 1 | 0 | No | No |
| 17230547 | STERILE URINARY CATHETER PACKAGE WITH DISPENSING SYSTEM | April 2021 | April 2024 | Allow | 36 | 0 | 0 | Yes | No |
| 17224311 | EYEDROPPER BOTTLE HOLDER | April 2021 | June 2023 | Allow | 26 | 0 | 0 | Yes | No |
| 17220706 | NEGATIVE-PRESSURE THERAPY WITH ADJUSTABLE INSTILLATION PUMP CHAMBER | April 2021 | July 2024 | Allow | 40 | 1 | 1 | No | No |
| 17210766 | Cleansing Device | March 2021 | January 2025 | Abandon | 46 | 0 | 1 | No | No |
| 17178285 | THREE-DIMENSIONAL SUBSTRATE AND ABSORBENT ARTICLES COMPRISING THE SAME | February 2021 | January 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17147196 | PIEZOELECTRIC DISPENSER WITH REPLACEABLE AMPOULE | January 2021 | March 2024 | Allow | 38 | 2 | 0 | Yes | No |
| 17141937 | SYSTEMS AND METHODS FOR REDUCING PRESSURE AT AN OUTFLOW OF A DUCT | January 2021 | June 2023 | Allow | 30 | 1 | 0 | No | No |
| 17141101 | FLUID COLLECTION SYSTEMS | January 2021 | April 2024 | Allow | 39 | 3 | 0 | No | No |
| 17115446 | TEMPLATE AND METHOD FOR REMOVING A TATTOO THROUGH PATTERNED TRANS-EPIDERMAL PIGMENT RELEASE | December 2020 | April 2024 | Allow | 41 | 1 | 0 | Yes | No |
| 17103522 | DEVICES AND METHODS FOR PLACING A GASTROINTESTINAL DEVICE | November 2020 | November 2023 | Allow | 36 | 1 | 1 | Yes | No |
| 17050106 | WOUND DRESSING FOR TREATMENT OF DAMAGED SKIN | October 2020 | April 2025 | Allow | 53 | 2 | 0 | No | No |
| 17044535 | SYSTEMS AND METHODS FOR DETERMINING BLOCKAGES IN A NEGATIVE PRESSURE WOUND THERAPY SYSTEM | October 2020 | June 2023 | Allow | 32 | 3 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner ARBLE, JESSICA R.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 21.1% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner ARBLE, JESSICA R works in Art Unit 3781 and has examined 316 patent applications in our dataset. With an allowance rate of 65.5%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 41 months.
Examiner ARBLE, JESSICA R's allowance rate of 65.5% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.
On average, applications examined by ARBLE, JESSICA R receive 2.34 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by ARBLE, JESSICA R is 41 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +26.9% benefit to allowance rate for applications examined by ARBLE, JESSICA R. This interview benefit is in the 74% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 26.2% of applications are subsequently allowed. This success rate is in the 43% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 20.1% of cases where such amendments are filed. This entry rate is in the 25% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 77% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 60.0% of appeals filed. This is in the 37% percentile among all examiners. Of these withdrawals, 44.4% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 26.7% are granted (fully or in part). This grant rate is in the 14% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.0% of allowed cases (in the 60% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.